A white paper published by the Institute for Clinical and Economic Review (ICER) established a series of recommendations and guidelines for health technology assessment that aim to address health care ...

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care. The life cycle of a drug encompasses phases of market exclusivity, ...

The field of early health technology assessment (HTA) and economic evaluation has evolved into a crucial facet of modern healthcare development. By providing preliminary assessments during the ...

The rapid evolution of medical devices poses unique challenges and opportunities in modern healthcare. Health Technology Assessment (HTA) has emerged as a critical mechanism to evaluate not only the ...

This article is part of a Health Affairs Forefront short series, “Enhancing Value By Evaluating Health Care Services.” The series discusses ways to extend the use of tools for clinical and economic ...